Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Humacyte Inc., 2 years.
Humacyte Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Humacyte Inc. June 9, 202684.9%
-
Humacyte Inc. June 11, 202499.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | Humacyte Inc. | Open-market purchase | +10,000 | $0.56 | $5,620 |
| Aug 20, 2026 | Humacyte Inc. | Open-market purchase | +10,000 | $0.69 | $6,930 |
| Aug 17, 2026 | Humacyte Inc. | Open-market purchase | +30,000 | $0.59 | $17,820 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.